Clinical Trial: A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title:

Brief Summary: This study will evaluate the safety and efficacy of an intravitreal implant of dexamethasone for the treatment of non-infectious intermediate or posterior uveitis.

Detailed Summary:
Sponsor: Allergan

Current Primary Outcome: Percentage of Patients With Vitreous Haze (Ocular Inflammation) Score of Zero [ Time Frame: Week 8 ]

Percentage of patients with Vitreous Haze Score of Zero at Week 8. Score is based on standardized scale of 0 to +4 where 0 equals no inflammation and +4 equals optic nerve head not visible (severe).


Original Primary Outcome: Vitreous Haze

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Allergan

Dates:
Date Received: June 2, 2006
Date Started: May 2006
Date Completion:
Last Updated: March 11, 2011
Last Verified: March 2011